Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-09-19

Clinical Trial Update: A Study to Evaluate Treatment Satisfaction With Erenumab in Participants With Migraine [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update reports results on patient treatment satisfaction with erenumab for migraine; the study has completed and results were posted in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AIMOVIG (ERENUMAB-AOOE)

Snippet

Sponsor: Amgen | Conditions: Migraine | Phase 4 | Status: COMPLETED | Results posted: 2024-09-19